Orphan Lung Diseases

Prof Vincent Cottin is coordinator of the national reference center for rare pulmonary diseases in France, with a 21 years experience in rare pulmonary diseases. He has coordinated the first edition of this book, together with Prof L. Richeldi (and Prof JF. Cordier, now retired). He is current section editor for the Eur Respir J (impact factor > 12), and past editor in chief of the Eur Respir Review. Prof Luca Richeldi is heading the interstitial lung disease clinic at the Gemelli hospital in Roma, Italy, and is an author of landmark publications in the field. Prof Kevin Brown is director of the interstitial lung disease program at the National Jewish Medical and Research Center in Denver, Colorado, one of the main centers for research and education in this field. Prof Frank M.X. McCormack is the principal investigator of the US Rare Lung Disease Network, and a expert in multiple cystic lung diseases and many other rare pulmonary diseases. All four editors are reknown leaders in the field of rare pulmonary diseases especially interstitial lung diseases, with a track record of original publication and review articles, as well as editorial experience.

Chapter 1. Orphan lung diseases: from definition to organisation of care.-Chapter 2. The challenge of clinical research in orphan diseases.- Chapter 3. Chronic bronchiolitis in adults.- Chapter 4. Allergic bronchopulmonary mycosis.- Chapter 5. Orphan tracheopathies.- Chapter 6. Amyloidosis of the lungs and airways.- Chapter 7. Eosinophilic granulomatosis with polyangiitis.- Chapter 8. Granulomatosis with polyangiitis.- Chapter 9. Alveolar hemorrhage.- Chapter 10. Pulmonary manifestations of large vessel vasculitis (Behçet and Takayasu disease) .- Chapter 11. Hepato-pulmonary syndrome.- Chapter 12. Systemic sclerosis and the lung.- Chapter 13. Rheumatoid arthritis and the lung.- Chapter 14. Lung disease in systemic lupus erythematosus, myositis, Sjögren disease and mixed connective tissue diseases.- Chapter 15. Interstitial pneumonia with autoimmune features, and overlap interstitial pneumonia.- Chapter 16. Non-Langerhans cell histiocytosis and the lung.- Chapter 17. Idiopathic eosinophilic pneumonias.- Chapter 18. Langerhans cell granulomatosis and smoking-related interstitial lung diseases.- Chapter 19. Lymphangioleiomyomatosis.- Chapter 20. Multiple cystic lung disease.- Chapter 21. Complex Thoracic Lymphatic Disorders of Adults.- Chapter 22. Pulmonary alveolar proteinosis.- Chapter 23. Gasteroesosophageal reflux, idiopathic pulmonary fibrosis and lung transplantation.- Chapter 24. Genetic and familial pulmonary fibrosis related to monogenic diseases.- Chapter 25. Diffuse bronchiectasis of genetic or idiopathic origin.- Chapter 26. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia.- Chapter 27. Pulmonary alveolar microlithiasis.- Chapter 28. Rare diffuse lung diseases of genetic origin.- Chapter 29. Imaging approach to interstitial lung disease.- Chapter 30. Bronchoscopic approach to interstitial lung disease.- Chapter 31. An integrated approach to diagnosing interstitial lung disease.- Chapter 32. Idiopathic Pulmonary fibrosis and the many faces of UIP.- Chapter 33. Combined pulmonary fibrosis and emphysema (syndrome) .- Chapter 34. Nonspecific interstitial pneumonia, idiopathic or secondary.- Chapter 35. Organising pneumonias and acute interstitial pneumonia.- Chapter 36. Pleuro pulmonary fibroelastosis.- Chapter 37.Interstitial lung diseases of occupational origin.- Chapter 38. Unclassifiable Interstitital Lung Disease.- Chapter 39. Lymphoproliferative lung diseases.- Chapter 40. Pulmonary manifestations of hematological malignancies and recipients of bone marrow or stem cell transplantation.- Chapter 41. Pulmonary hypertension in orphan lung diseases.- Chapter 42. Drug-induced / iatrogenic respiratory disease: With emphasis on unusual, rare and emergent drug-induced reactions.- Chapter 43. Malignant mimics of orphan lung diseases.